Improving the quality of cancer clinical trials workshop summary / National Cancer Policy Forum, Margie Patlack and Sharyl Nass, Rapporteurs.

Format Electronic
Publication InfoWashington, D.C. : National Academies Press,
Descriptionxii, 124 p. : ill. (some col.) ; 23 cm.
Supplemental ContentFull text available from Ebook Central - Academic Complete
Subjects

Other author/creatorPatlak, Margie.
Other author/creatorNass, Sharyl J.
Other author/creatorNational Cancer Policy Forum (U.S.)
Other author/creatorInstitute of Medicine (U.S.)
Contents Introduction -- New clinical trial designs. Phase 0 trials -- Adaptive trial designs -- Targeting multiple pathways with multiple drugs -- Preclinical model systems -- Molecular imaging. Current and developing methods -- Challenges of molecular imaging -- Screening for predictive markers. The challenges of clinical validation -- Bioimaging predictive markers -- Clinical translation -- Panel discussion -- Costs of clinical trials. Regulatory costs -- Patient accrual -- Global outsourcing -- Time is money -- Public-private collaborations -- Regulatory issues. Regulatory barriers to innovation -- Patient advocacy perspective -- Regulation of in vitro diagnostics -- Regulatory issues in improving cancer clinical trials -- Reports from the case study discussion groups. Adaptive trial design -- Phase 0 trials -- Imaging -- Use of proteomics/genomics to assign therapy in lung cancer -- Use of genetics/genomics to assign therapy.
Bibliography noteIncludes bibliographical references.
Access restrictionAvailable only to authorized users.
Other formsAlso available on the World Wide Web.
Technical detailsMode of access: World Wide Web
Genre/formElectronic books.
LCCN 2008299448
ISBN9780309116688
ISBN0309116686

Availability

Library Location Call Number Status Item Actions
Electronic Resources Access Content Online ✔ Available